Using microneedle arrays developed at Carnegie Melon, microdosed with a known chemotherapeutic agent delivered directly to ...

The Oligonucleotides for CNS Summit returns for its 5 th year to address key challenges in durability, scalability, potency ...

A third fatality has been recorded among patients receiving treatment with a Sarepta gene therapy, adding to the troubles ...

Just over two years into Anderson's tenure, Bayer's board has decided to extend his contract by three years to 31st March ...

The panel expressed concerns about the proposed doses of Blenrep (belantamab mafodotin) in GSK's marketing application, ...

With the rise of advanced simulation and model-informed drug development (MIDD) techniques like digital twins, researchers ...

The UK government has revealed a plan to open a biosecurity facility in Harlow, Essex, to help protect the country from ...

The direct-to-consumer (DTC) platform – called Eliquis 360 Support – will offer Eliquis (apixaban) to patients who pay for ...

The Market Access for CNS Therapeutics Summit is the only dedicated forum focused on tackling the unique commercial and ...

An antibody being developed by AstraZeneca for the treatment of light chain (AL) amyloidosis has failed to move the needle in ...

Engaging all stakeholders in the process of establishing a global MI service is key to its overall success. Each ...

Developing new biomarker assays is highly specialised work. It requires careful screening of antibody pairs, sensitivity and ...